Form 8-K

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15 (d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

November 10, 2008

 

 

FMC CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   1-2376   94-0479804

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

1735 Market Street, Philadelphia, PA 19103

(Address of principal executive offices) (Zip Code)

(215) 299-6000

Registrant’s telephone number, including area code

 

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act

 

¨ Soliciting material pursuant to Rule 14a-2 under the Exchange Act

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

 

 


Item 7.01. Regulation FD Disclosure.

On November 10, 2008, Mr. Brennen M. Arndt, Director, Investor Relations of FMC Corporation, met with investors at the Ingalls & Snyder LLC Seminar for Specialty Chemical Companies in New York, NY. Slides used in his presentation at the meeting are included hereto as an exhibit.

This report is not deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

99.1 FMC presentation by Brennen M. Arndt at the Ingalls & Snyder LLC Seminar for Specialty Chemical Companies in New York, NY on November 10, 2008.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

FMC CORPORATION
By:  

/s/    W. KIM FOSTER

 

W. Kim Foster

Senior Vice President and

Chief Financial Officer

Date: November 10, 2008


EXHIBIT INDEX

 

Exhibit
Number

  

Description

99.1

   FMC presentation by Brennen M. Arndt at the Ingalls & Snyder LLC Seminar for Specialty Chemical Companies in New York, NY on November 10, 2008.